Abstract
Insomnia is a prevalent sleep disorder that is typically comorbid with medical, psychiatric, and other sleep disorders. Yet, it is a disorder with its own course and morbidity that can persist if untreated. This chapter describes the physiological correlates of insomnia expressed during sleep and during the daytime. Together, the data from nighttime and daytime electrophysiology, event-related brain potential recording, neuroimaging studies, sympathetic nervous system, and HPA axis monitoring all suggest that insomnia is a 24 h disorder of hyperarousal.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (DSM5). American Psychiatric Association, Washington, DC
Baglioni C, Regen W, Teghen A, Spiegelhalder K, Feige B, Nissen C, Riemann D (2014) Sleep changes in the disorder of insomnia: a meta-analysis of polysomnographic studies. Sleep Med Rev 18:195–213
Bastien C, St-Jean G, Morin C (2008) Chronic psychophysiological insomnia: hyperarousal and/or inhibition deficits? an ERPs investigation. Sleep 31:887–898
Bonnet MH, Arand DL (1995) 24-hour metabolic rate in insomniacs and matched normal sleepers. Sleep 18:581–588
Bonnet MH, Arand DL (2006) Consequences of insomnia. Sleep Med Clin 1:351–358
Bonnet MH, Doghramji K, Roehrs T et al (2007) The scoring of arousal in sleep: reliability, validity, and alternatives. J Clin Sleep Med 3:133–145
Born J, Spath-Schwalbe E, Schwakenhofer H, Kern W, Fehm HL (1989) Influences of corticotrophin-releasing hormone, adrenocorticotropin, and cortisol on sleep in normal man. J Clin Endocrinol Metab 68:904–911
Butler PD, Weiss JM, Stout JC, Nemeroff CB (1990) Corticotropin-releasing factor produces fear-enhancing and behavioral activation effects following infusion into the locus coeruleus. J Neurosci 10:176–183
Buysse DJ, Germain A, Hall M et al (2008) EEG spectral analysis in primary insomnia: NREM period effects and sex differences. Sleep 31:1673–1682
Carskadon MA, Dement WC, Mitler MM (1976) Self reports versus sleep laboratory findings in 122 drug-free subjects with complaints of primary insomnia. Am J Psychiatry 133:1382–1387
Carskadon MA, Dement WC (2011) Normal human sleep: an overview. In: Kryger MH, Roth T, Dement WC (eds) Principles and practice of sleep medicine, 5th edn. Elsevier Saunders, St Louis, pp 16–26
Devoto A, Violani C, Lucidi F, Lombardo C (2003) P300 amplitude in subjects with primary insomnia is modulated by their sleep quality. J Psychosom Res 54:3–10
Devoto A, Manganelli S, Lucidi F, Lombardo C, Russo M, Violani C (2005) Quality of sleep and P300 amplitude in primary insomnia: a preliminary study. Sleep 28:859–863
Drake C, Roehrs T, Burduvali E, Bonahoom A, Rosekind M, Roth T (2001) Effects of rapid versus slow accumulation of eight hours of sleep loss. Psychophysiology 38:979–987
Drake CL, Roehrs T, Roth T (2003) Insomnia causes, consequences, and therapeutics: an overview. Dep Anx 18:163–176
Gold PW, Chrousos GP (2002) Organization of the stress system and its dysregulation in melancholic and atypical depression: high versus low CRH/NE states. Mol Psychiatry 7:254–275
Gillin JC, Duncan W, Pettigrew KD et al (1979) Successful separation of depressed, normal, and insomniac subjects by EEG sleep data. Arch Gen Psychiatry 36:85–90
Guymenyuk V, Belcher R, Drake CL, Spear L, Roth T (2014) Cortical arousal is present in alert insomniacs, but absent in sleepy insomniacs with shift work disorders. Presented at Sleep 2014, Minneapolis, June 2014
Holsboer F, von Bardeleben U, Steiger A (1988) Effects of intravenous corticotrophin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man. Neuroendocrinology 48:32–38
Johnson EO, Roth T, Breslau N (2006) The association of insomnia with anxiety disorders and depression: exploration of the direction of risk. J Psychiatric Res 40:700–708
Kalk NJ, Nutt DJ, Lingford-Hughes AR (2011) The role of central noradrenergic dysregulation in anxiety disorders: evidence from clinical studies. J Psychopharm 25:3–16
Krystal AD, Edinger JD, Wohlgemuth WK et al (2002) NREM sleep EEG frequency correlates of sleep complaints in primary insomnia subtypes. Sleep 25:626–636
Krystal AD (2006) Psychiatric comorbidity: the case for treating insomnia. Sleep Med Clin 1:359–365
Lichstein KL, Wilson NM, Noe SL, Aguillard RN, Bellur SN (1994) Daytime sleepiness in insomnia: behavioral, biological and subjective indices. Sleep 17:693–702
Lichstein KL, Johnson RS (1994) Pupillometric discrimination in insomniacs. Behav Res Ther 32:123–129
Lushington K, Dawson D, Lack L (2000) Core body temperature is elevated during constant wakefulness in elderly poor sleepers. Sleep 23:504–510
Matsumoto K, Ojima K, Watanabe H (1997) Central corticotrophin-releasing factor and benzodiazepine receptor systems are involved in the social isolation stress-induced decrease in ethanol sleep in mice. Brain Res 753:318–321
Mendelson WB, James SP, Garnett D et al (1986) A psychophysiological study of insomnia. Psychiatry Res 16:267–284
Mercia H, Blois R, Gaillard JM (1998) Spectral characteristics of sleep EEG in chronic insomnia. Eur J Neurosci 10:1826–1834
NIH: National Institutes of Health State of the Science Conference Statement (2005) Manifestations and management of chronic insomnia in adults. Sleep 28:1049–1057 June 13–15
Nofzinger EA, Buysee DJ, Germain A, Price JC, Miewald JM, Kupfer DJ (2004) Functional neuroimaging evidence for hyperarousal in insomnia. Am J Psychiatry 161:2126–2129
Nofzinger EA, Nissen C, Germain A, Moul D, Hall M, Price J (2006) Reginal cerebral metabolic correlates of WASO during NREM sleep in insomnia. J Clin Sleep Med 2:316–322
Page ME, Abercrombie ED (1999) Discrete local application of corticotrophin-releasing factor increases locus coeruleus discharge and extracellular norepinephrine. Synapse 33:304–313
Perlis ML, Smith MT, Andrews PJ et al (2001) Beta/gamma EEG activity in patients with primary and secondary insomnia and good sleeper controls. Sleep 24:110–117
Richardson GS, Roth T (2001) Future directions in the management of insomnia. J Clin Psychiatry 62(suppl 10):39–45
Riemann D, Klein T, Rodenbeck A, Feige B, Horney A, Hummel R (2002) Nocturnal cortisol and melatonin secretion in primary insomnia. Psychiatry Res 113:17–27
Roehrs TA, Randall S, Harris E et al (2011) MSLT in primary insomnia: stability and relation to nocturnal sleep. Sleep 13:1647–1652
Roehrs T, Diederichs C, Gillis M et al (2013) Nocturnal sleep, daytime sleepiness and fatigue in fibromyalgia patients compared to rheumatoid arthritis patients and healthy controls: a preliminary study. Sleep Med 14:109–115
Roehrs T, Randall S, Roth T (2012) Daytime urinary norepinepherine levels in hyperaroused insomniacs. Presented at Sleep 2012, Boston, June 2012
Rodenbeck A, Huether G, Ruether E, Hajak G (2002) Interactions between evening and nocturnal cortisol secretion and sleep parameters in patients with severe chronic primary insomnia. Neurosci Lett 324:163–459
Roth T, Roehrs T, Pies R (2007) Insomnia: pathophysiology and implications for treatment. Sleep Med Rev 11:71–79
Roth T, Bhadra-Brown P, Pitman VW et al (2014) Characteristics of disturbed sleep in patients with fibromyalgia compared with insomnia or with healthy volunteers. J Rheumatol (Submitted paper in review)
Salin-Pascual RJ, Roehrs TA, Merlotti LA et al (1992) Long-term study of the sleep of insomnia patients with sleep-state misperception and other insomnia patients. Am J Psychiatry 149:904–908
Schutte-Rodin S, Broach L, Buysse D et al (2008) Clinical guideline for evaluation and management of chronic insomnia in adults. J Clin Sleep Med 4:487–504
Stepanski E, Lamphere J, Badia P et al (1984) Sleep fragmentation and daytime sleepiness. Sleep 7:18–26
Stepanski E, Zorick F, Roehrs T et al (1988) Daytime alertness in patients with chronic insomnia compared with asymptomatic control subjects. Sleep 11:54–60
Stepanski E, Zorick F, Roehrs T et al (2000) Effects of sleep deprivation on day sleepiness in primary insomnia. Sleep 23:1–5
Swanson LW, Sawchenko PE, River J, Vale WW (1983) Organization of ovine corticotrophin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36:165–186
Terzano MG, Parrino L, Spaggiari MC et al (2003) CAP variables and arousals as sleep electroencephalogram markers for primary insomnia. Clin Neurophysiol 114:1715–1723
Yang CM, Lo HS (2007) ERP evidence of enhanced excitatory and reduced inhibitory processes of auditory stimuli during sleep in patients with primary insomnia. Sleep 30:585–592
Vgontzas AN, Tsigos C, Bixler EO (1998) Chronic insomnia and activity of the stress system: a preliminary study. J Psychosom Res 45:21–31
Vgontzas AN, Bixler EO, Lin HM, Prolo P, Mastorakos G, Vela-Bueno A et al (2001) Chronic insomnia is associated with nycthemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab 86:3787–3794
Vgontzas AN, Fernandez-Mendoza F, Liao D (2013) Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. Sleep Med Rev 24:241–254
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Roehrs, T., Gumenyuk, V., Drake, C., Roth, T. (2014). Physiological Correlates of Insomnia. In: Kumari, V., Bob, P., Boutros, N. (eds) Electrophysiology and Psychophysiology in Psychiatry and Psychopharmacology. Current Topics in Behavioral Neurosciences, vol 21. Springer, Cham. https://doi.org/10.1007/7854_2014_324
Download citation
DOI: https://doi.org/10.1007/7854_2014_324
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-12768-2
Online ISBN: 978-3-319-12769-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)